CPA
GSK icon

Court Place Advisors’s GSK GSK Stock Holding History

Court Place Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,180
Closed -$244K – 176
2020
Q3 		$244K Hold
5,180
– – 0.09% 146
2020
Q2 		$264K Hold
5,180
– – 0.1% 139
2020
Q1 		$245K Sell
5,180
-160
-3% -$8.54K 0.11% 136
2019
Q4 		$314K Sell
5,340
-400
-7% -$22.3K 0.11% 141
2019
Q3 		$306K Hold
5,740
– – 0.12% 139
2019
Q2 		$287K Sell
5,740
-320
-5% -$16.1K 0.11% 145
2019
Q1 		$317K Hold
6,060
– – 0.13% 130
2018
Q4 		$289K Hold
6,060
– – 0.13% 132
2018
Q3 		$304K Sell
6,060
-276
-4% -$14K 0.12% 135
2018
Q2 		$319K Sell
6,336
-445
-7% -$22.4K 0.13% 128
2018
Q1 		$331K Buy
6,781
+160
+2% +$7.45K 0.14% 130
2017
Q4 		$294K Sell
6,621
-720
-10% -$33.3K 0.12% 133
2017
Q3 		$373K Buy
7,341
+556
+8% +$28.2K 0.17% 117
2017
Q2 		$366K Hold
6,785
– – 0.17% 113
2017
Q1 		$358K Buy
6,785
+67
+1% +$3.4K 0.18% 113
2016
Q4 		$323K Sell
6,718
-120
-2% -$5.93K 0.17% 113
2016
Q3 		$369K Hold
6,838
– – 0.21% 101
2016
Q2 		$370K Sell
6,838
-80
-1% -$4.21K 0.21% 96
2016
Q1 		$351K Buy
6,918
+200
+3% +$9.96K 0.22% 93
2015
Q4 		$339K Sell
6,718
-320
-5% -$16.3K 0.22% 89
2015
Q3 		$338K Sell
7,038
-640
-8% -$33.3K 0.23% 86
2015
Q2 		$400K Hold
7,678
– – 0.26% 87
2015
Q1 		$443K Hold
7,678
– – 0.28% 83
2014
Q4 		$410K Buy
7,678
+220
+3% +$12.3K 0.27% 84
2014
Q3 		$429K Buy
7,458
+640
+9% +$39.2K 0.29% 80
2014
Q2 		$456K Hold
6,818
– – 0.32% 75
2014
Q1 		$455K Buy
6,818
+320
+5% +$21.6K 0.33% 68
2013
Q4 		$434K Buy
+6,498
New +$421K 0.33% 69

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Court Place Advisors's GSK Position: Q4 2020 in Review

Court Place Advisors sold out of GSK (GSK) in Q4 2020, closing a stake of 5,180 shares — an estimated $244K sold.

Court Place Advisors first reported a position in GSK in Q4 2013 and held it in 28 quarters. The position peaked at $456K in Q2 2014. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

  • Court Place Advisors reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
  • Court Place Advisors sold 5,180 GSK shares in Q4 2020, an estimated $244K.
  • Court Place Advisors first reported a position in GSK in Q4 2013 and held it in 28 quarters.
  • Court Place Advisors's GSK position peaked at $456K in Q2 2014.
  • 818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Court Place Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.